Mouse Polyclonal ULBP2 antibody. Suitable for Flow Cyt, WB and reacts with Human samples. Cited in 4 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human ULBP2.
View Alternative Names
N2DL2, RAET1H, UNQ463/PRO791, ULBP2, UL16-binding protein 2, ALCAN-alpha, NKG2D ligand 2, Retinoic acid early transcript 1H, N2DL-2, NKG2DL2
- Flow Cyt
Unknown
Flow Cytometry - Anti-ULBP2 antibody (AB88645)
ab88645 detecting ULBP2 in ULBP2-expressing 293 cells (Green) compared with negative control 293 cells (Black) by flow cytometry.
- WB
Unknown
Western blot - Anti-ULBP2 antibody (AB88645)
All lanes:
Western blot - Anti-ULBP2 antibody (ab88645) at 1 µg/mL
All lanes:
Human ovary cancer tissue lysate at 50 µg
Predicted band size: 27 kDa
Observed band size: ~35 kDa
false
- WB
Unknown
Western blot - Anti-ULBP2 antibody (AB88645)
All lanes:
Western blot - Anti-ULBP2 antibody (ab88645) at 1 µg/mL
Lane 1:
cell lysate from ULBP2 transfected 293T cells at 25 µg
Lane 2:
cell lysate from non transfected 293T cells at 25 µg
Predicted band size: 27 kDa
Observed band size: ~27 kDa,~29 kDa,~33 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The function of ULBP2 is to facilitate the activation of natural killer (NK) cells and cytotoxic T lymphocytes through binding to the NKG2D receptor. ULBP2 is not a part of a complex but acts independently to trigger immune responses. By interacting with NKG2D ULBP2 promotes the release of cytokines and enhances the cytolytic activity of these immune cells leading to the destruction of infected or transformed cells. This mechanism allows the immune system to efficiently target and eliminate compromised cells.
Pathways
The interaction between ULBP2 and the NKG2D receptor forms a critical part of the immune surveillance pathway. This pathway detects and responds to cellular abnormalities such as tumorigenesis or viral infections. ULBP2's activity relates closely with other NKG2D ligands and components of the immune checkpoint pathways notably involving proteins like MICA and MICB. Additionally ULBP2’s interaction impacts the balance between activating and inhibitory signals within the NK cell cascade thereby influencing immune system homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Oncology letters 26:297 PubMed37274476
2023
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10:e2202519 PubMed36683155
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncoimmunology 9:1845424 PubMed33299656
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer research 75:1603-14 PubMed25762540
2015
Applications
WB
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com